BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10575186)

  • 1. Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in chronic renal failure and effects of renal replacement therapy.
    Frieling JT; van Hamersvelt HW; Wijdenes J; Hendriks T; Sauerwein RW; van Der Linden CJ
    Am J Nephrol; 1999; 19(5):571-5. PubMed ID: 10575186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of soluble TNF-alpha receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis.
    Rysz J; Majewska E; Stolarek RA; Banach M; Ciałkowska-Rysz A; Baj Z
    Am J Nephrol; 2006; 26(5):437-44. PubMed ID: 16988495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines, adipocytokines and inflammatory markers in patients on continuous ambulatory peritoneal dialysis and hemodialysis.
    Oncel M; Akbulut S; Toka Ozer T; Kiyici A; Keles M; Baltaci B; Turk S
    Ren Fail; 2016 Aug; 38(7):1071-5. PubMed ID: 27267129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J
    Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.
    Davas EM; Tsirogianni A; Kappou I; Karamitsos D; Economidou I; Dantis PC
    Clin Rheumatol; 1999; 18(1):17-22. PubMed ID: 10088943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative flow cytometry shows activation of the TNF-alpha system but not of the IL-2 system at the single cell level in renal replacement therapy.
    van Riemsdijk-Van Overbeeke IC; Baan CC; Knoop CJ; Loonen EH; Zietse R; Weimar W
    Nephrol Dial Transplant; 2001 Jul; 16(7):1430-5. PubMed ID: 11427636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure.
    van Riemsdijk-van Overbeeke IC; Baan CC; Hesse CJ; Loonen EH; Niesters HG; Zietse R; Weimar W
    Clin Nephrol; 2000 Feb; 53(2):115-23. PubMed ID: 10711413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
    Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure.
    Hirota H; Izumi M; Hamaguchi T; Sugiyama S; Murakami E; Kunisada K; Fujio Y; Oshima Y; Nakaoka Y; Yamauchi-Takihara K
    Heart Vessels; 2004 Sep; 19(5):237-41. PubMed ID: 15372299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentration of IL-2, IL-6, TNF-alpha and their soluble receptors in children on maintenance hemodialysis.
    Zwolińska D; Medyńska A; Szprynger K; Szczepańska M
    Nephron; 2000 Dec; 86(4):441-6. PubMed ID: 11124592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), and their soluble receptors in coal workers' pneumoconiosis.
    Zhai R; Liu G; Ge X; Bao W; Wu C; Yang C; Liang D
    Respir Med; 2002 Oct; 96(10):829-34. PubMed ID: 12412984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.
    Pereira BJ; Shapiro L; King AJ; Falagas ME; Strom JA; Dinarello CA
    Kidney Int; 1994 Mar; 45(3):890-6. PubMed ID: 8196293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
    Goldstein SL; Leung JC; Silverstein DM
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
    Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
    Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
    Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.